本报道最初发表于Endpoints News。请点击这里查看原文
Craig Crews has incubated some notable biotech companies this century, and hundreds of thousands of blood cancer patients have benefited from a medicine with roots in his Yale lab.
本世纪以来,克雷格•克鲁斯(Craig Crews)孵化了多家知名生物技术公司,而源自他在耶鲁(Yale)实验室的一种药物已让数十万名血液肿瘤患者受益。
您已阅读6%(288字),剩余94%(4848字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。